M acrophages (MFs) maintain organ homeostasis, facilitate host defense and wound healing, but also underlie the pathogenesis of many chronic diseases (1) . This functional dichotomy arises from their intrinsic plasticity, causing polarization into distinct functional phenotypes depending on the environmental stimuli. For instance, classically activated or M1-like MFs become more proinflammatory and bactericidal in the presence of IFN-g and LPS, whereas alternatively activated or M2-like MFs are immunoregulatory, and can promote wound healing and modify the extracellular matrix through the secretion of proteases and growth factors (2, 3) . Because there is complex overlap between tissue homeostasis, inflammation, and disease pathogenesis, it is now thought that distinct MF subpopulations may exist that subserve their protective or pathogenic roles (1) . A prime example may be in lungs, where residential alveolar MFs (AMFs) are simultaneously implicated to play many homeostatic (4), proinflammatory (5, 6) , and pathogenic roles (7, 8) .
In healthy adult lungs, AMFs exist as the predominant cell type (98% + ) in the alveolar airspaces. There, they sit as a uniform, quiescent, and immunosuppressive population capable of pathogen phagocytosis and T cell recruitment in the early event of a bacterial or viral infection (9, 10) . Cell turnover rate is slow (11) and is maintained by constitutively immigrating CCR2
2 Gr-1 2 resident monocytes (12, 13) . In contrast, CCR2 + Gr-1 + inflammatory monocytes rapidly migrate into alveolar airspaces after lung infection and are believed to be the main effectors of acute lung injury and infection-related mortality (6, 14, 15) . Increased AMFs, however, are correlated with the severity of chronic obstructive pulmonary disease (COPD) (16) , a debilitating chronic condition characterized by progressive irreversible airflow limitation and lung parenchyma destruction. Altered AMF behavior is also observed in animal models of COPD, chronic lung inflammation, and tumorigenesis (7, 8, 17, 18) , making the behavior of lung MFs an important field of study.
Unfortunately, efforts to identify AMF subsets in the lung microenvironment have been severely hampered by their intense cell autofluorescence (19) , unlike inflammatory lung monocytes (or "exudate" lung MFs), which are less autofluorescent, easier to study by flow cytometry, and thus better characterized. Altogether, this has created a gap in our understanding of AMF heterogeneity and their roles in the orchestration of host defense, inflammation, and disease. In this article, we demonstrate that AMF autofluorescence emission diminishes above 640 nm, enabling us to establish a modified flow cytometry method using fluorophoreconjugated Abs that emit at wavelengths (ls) .660 nm. Screening LPS-treated and influenza-infected C57BL/6 mice, we found that MF heterogeneity to be a prominent component of the acute lung immune response, distinctly characterized by three MF subpopulations present in the alveolar airspaces (CD11c Mac-1 high monocytes). Subpopulations displayed distinct gene profiles independent of an exclusive M1 or M2 polarization signature, with restoration to the CD11c high Mac-1 neg/low subpopulation marking resolution and the reinstatement of lung homeostasis. Chronic inflammatory lung disease was then investigated using SHIP-1-deficient mice, where AMF polarization was first identified as an effector of chronic lung disease and tumorigenesis (8) . AMF subpopulation deregulation (marked by an additional subpopulation of residential CD11c high Mac-1 pos AMFs) was found to be a prominent novel feature of SHIP-1-deficient mice and tracked specifically with lung disease pathogenesis. Altogether, our studies suggest a novel role for AMF subpopulations and Mac-1 signaling in the regulation of AMF activation, acute infection, and chronic inflammatory lung disease. 
Materials and Methods

LPS and Mem71 virus challenge
Ten-to 12-wk-old mice were challenged with a 30 ml transnasal administration of E. coli LPS (10 mg/mouse, serotype O114:B4; Sigma) or Mem71 influenza virus (31,000 PFU/mouse, sublethal dose), and euthanized at 24 h, 72 h, and day 10. Bronchoalveolar lavage (BAL) cells were collected as described later. Control mice received 30 ml DMEM.
Acute cigarette smoke exposure C57BL/6 mice were exposed to cigarette smoke for 4 consecutive days (22) , euthanized on day 5, and BAL cells collected. Control mice were housed in identical chambers that did not receive cigarette smoke.
Creation of CD45.2 bone marrow chimeras
Bone marrow (BM) was extracted aseptically from femurs of 6-wk-old donor BL6.SJL-Prptc a mice (CD45.1 allotype), washed, filtered, and resuspended in 2% FCS + PBS. Four-to 6-wk-old recipient C57BL/6 mice (CD45.2 allotype) received two equal doses of total body irradiation (550 rad), separated by 3 h. One hour postirradiation, recipients received 4 3 10 5 BL6.SJL-Prptc a donor BM cells through lateral tail vein injection, and mice were then given oral antibiotics for 2 wk postirradiation. Four weeks postirradiation, chimeric mice were challenged with LPS, Mem71 virus, or DMEM; euthanized; and BAL and peripheral blood collected for flow cytometry.
Lung histology
Lungs were inflation fixed in 4% PFA at 25 cm water pressure, removed, and paraffin embedded. Four-micrometer sections were stained with H&E or Masson's trichrome (MT). Images were captured using 310 and 320 objectives (Nikon Eclipse 90i).
BAL and peritoneal cell collection
Peritoneal cells were obtained from the peritoneum with PBS (5 ml). The trachea was cannulated and one 0.4-ml followed by three 0.3-ml aliquots of PBS sequentially aspirated and retrieved from the lungs to collect BAL cells. Cell counts were performed using a nucleocounter (Chemotec). BAL cells were resuspended in RBC lysis buffer (0.83% NH 4 Cl-Tris buffer, 37˚C, 3 min) and washed in FACS buffer before FACS analysis and cell sorting.
Spectral scanning of MF autofluorescence
Spectral scanning was performed using a confocal laser-scanning microscope (Olympus FV1000). Cells were excited using 473-nm lines from a solid-state laser (Olympus, Tokyo, Japan), and spectral scans (xyl) taken between 480 and 680 nm (20-nm steps, 240-mm pinhole). Transmitted light images were taken after each spectral scan, and cells were identified based on morphology. Settings were consistent between samples with photobleaching at ,3 and ,7% for C57BL/6 and SHIP-1 2/2 MFs, respectively. Images were captured using 603 water immersion objective (4.833 zoom, 512 3 512 pixels). Virtual l stacks were visualized using ImageJ software, and MF emission spectra was calculated as an average of the mean fluorescent intensity versus emission l of $8 MFs.
Flow cytometry analysis and cell sorting
Peritoneal and BAL cells were resuspended in FACS buffer (PBS, 2% FCS, 2 mM EDTA), filtered, and incubated with Fc block (0.5 mg/ml, 10 min; BD Biosciences). Cells were stained with 1˚mAbs (20 min, 4˚C on ice) followed by streptavidin allophycocyanin-Alexa Fluor 750 where necessary (15 min, 4˚C on ice; Invitrogen). To examine AMFs, we used anti-mouse CD45-FITC (BD Biosciences) to first positively select all leukocytes in BAL, and thus gate out BAL debris. Anti-mouse Ly6g-PE (BD Biosciences) was then used to negatively gate out all neutrophils, and all lymphocytes were gated out based on forward scatter (FSC) and side scatter (SSC). This allowed FACS analysis on the remaining MF/monocyte subpopulations using anti-mouse CD11c-allophycocyanin, CD11c-biotin, Ly6c-biotin, class II IA-b-biotin, CD36-allophycocyanin, CD124-biotin, and CD40-biotin (all from BD Biosciences); Mac-1-Pe-Cy7, CD14-PerCP-Cy5.5, and CD23-Pe-Cy7 (eBioscience); and F4/80-biotin and AFS98-biotin (gift from J. Hamilton, University of Melbourne). Data were acquired on a FACSAria (BD Biosciences), which collected $5000 AMF events. Analysis was performed using FlowJo software (Mac V8.7.3). Total BAL cell counts were performed using a nucleocounter (Chemotec), with absolute cell numbers calculated as total BAL cell number 3 percentage of cell subpopulation as determined by FACS (using CD45 
RNA isolation and qRT-PCR
Sorted BAL cells were pelleted, resuspended in 350 ml RLT plus buffer + 2-ME (Qiagen), snap frozen in liquid nitrogen, and stored at 270˚C. RNA was isolated using the RNeasy Plus Micro Kit (Qiagen), and quality and concentration were measured (Nanodrop). For independent experiments, a consistent amount of RNA/sample (200-300 ng) was converted to cDNA (Superscript VILO cDNA Synthesis Kit; Invitrogen) and diluted 1:1.5 in RNase-free H 2 O. Genes of interest were screened using preoptimized and validated TaqMan assays. Reaction mix consisted of 2 ml cDNA, 0.5 ml target primer, and 5 ml TaqMan Universal PCR Mastermix diluted with 2.5 ml RNase-free H 2 O and run for 40 cycles under fast single-plex conditions (ABI 7900ht). Eukaryotic 18S rRNA (Applied Biosystems) was used as endogenous control for all samples. For each gene target, a no-RT negative control was used to check against nonspecific binding to genomic DNA. Cycle threshold (C T ) values were calculated using automatic threshold analysis (SDS 2.3 software; Applied Biosystems) and taken as an average of duplicates. The relative expression of each target gene was calculated using the 2 2DDCT method (normalized to 18S control and relative to DMEM R control, or LPS R when DMEM R transcript undetectable). Results were calculated from a total of four independent experiments. All RNA samples were prepared together and run on a single plate to ensure that each independent experiment produced data all directly compared with control R.
Statistical analysis
Statistical analyses were performed using GraphPad Prism V.4.03. Values are expressed as mean 6 SEM from two or more independent experiments. The unpaired two-tailed Student t test was used for all excepting qRT-PCR data, which were analyzed using the two-tailed Mann-Whitney U test. their intrinsically high autofluorescence. We used confocal microscopy to perform spectral scanning of AMF emission ls. AMFs were significantly more autofluorescent than peritoneal MFs, with emission peaking around the emission ls of traditional fluorophores FITC and PE, but not allophycocyanin (Fig. 1A, 1B ). As expected, flow cytometry using traditional FITC-or PE-conjugated Abs produced only a small shift in positive (i.e., CD11c) staining because of the high background noise from AMF autofluorescence (Fig. 1C) . Because this autofluorescence greatly diminishes at l . 660 nm, fluorophores that emitted beyond this l (i.e., allophycocyanin, Pe-Cy7, and allophycocyanin-Alexa Fluor 750) were then put under trial. These produced a clear separation between negative and positive AMF staining, and revealed that AMFs were CD11c high Mac-1 neg/low (Fig. 1C) , assenting with previous studies of rat AMFs where differential surface Ag staining could be discretely distinguished using allophycocyanin (23) . Although clinical study has suggested that basal AMF autofluorescence derives from acquired tobacco tar exposure (24), we show that resting mouse AMFs are intrinsically more autofluorescent compared with peritoneal MFs, further emphasizing the necessity of our methodological approach.
We first tested a panel of M1 and M2 surface markers, but did not identify distinct AMF subpopulations (Supplemental Fig. 1A ). Leukocyte integrins play an important role in monocyte migration and activation, and are differentially expressed by blood monocyte subsets (25) . Thus, we assayed the expression of leukocyte integrins CD11a, CD11b (Mac-1), and CD11c in AMFs from control and LPS-treated mice. Only Mac-1 expression was found to be differentially distributed in LPS-treated, but not control AMFs (Fig. 1D) . Using CD11c and Mac-1 as subpopulation markers, we then investigated the behavior of AMFs in different respiratory conditions.
AMF subpopulations identified after LPS and virus challenge in mice
To detect AMF populations during acute lung infection, we first studied C57BL/6 mice 72 h post-LPS and Mem71 influenza virus challenge, because this is when initial lung neutrophilia subsides and MFs become prominent. As expected, LPS challenge elicited an acute inflammatory response with alveolar airspace infiltration by mononuclear cells, especially near regions of pulmonary blood vessels ( Fig. 2A) . BAL MF, neutrophil, and lymphocyte numbers were significantly higher compared with DMEM-treated (i.e., control) mice (Fig. 2B) , as reflected by the altered BAL cell FSC versus SSC (Fig. 2A) .
We identified three BAL MF subpopulations in mice challenged with LPS or Mem71 influenza virus. In control mice, residential AMFs were .95% CD11c high Mac-1 neg/low (subpopulation R), and were c-fms pos and Ly6c neg (Fig. 2C) . After LPS challenge, three MF subpopulations appeared in BAL: "residential" CD11c Mac (Fig. 2C) . MFs are believed to polarize into either a classically activated M1-like or alternatively activated M2-like phenotype (2, 3), although how this manifests in the dynamic tissue microenvironment remains unclear. To assess this, we used our gating strategy to sort each AMF subpopulation and examined for differences in morphology and M1/M2 gene expression. Mac-1 high (Me and Mv) monocytes were morphologically distinct from both residential and intermediate BAL MFs, appearing as highly vacuolated cells with irregular-shaped nuclei (Fig. 2D, Supplemental Fig. 1B) . For gene profiling, we focused on all AMF subpopulations from LPS-treated mice because LPS is a classical and well-studied M1 polarizing stimulus (3), together with subpopulation Mv in Mem71-infected mice because of its differential surface phenotype. Compared with residential AMFs (subpopulation R) in control mice, Mac-1 gene expression was significantly upregulated in intermediate BAL MFs and monocytes (subpopulation I and Me and Mv) as expected (Fig. 2E) . Interestingly, both M1 and M2 signatures were upregulated in BAL monocytes from LPS-and Mem71-challenged mice. Inducible NO synthase (iNOS) was higher in all subpopulations compared with residential AMFs from control mice. Upregulation of the classical M2 marker arginase I (Arg I) was simultaneously observed in the intermediate and monocyte subpopulation from LPS-treated mice and in Mem71-infected monocytes (Fig. 2E) . Both IL-6 (a known M1 MF cytokine) and IL-10 (the classical M2 MF cytokine) were simultaneously upregulated in LPS and Mem71 monocyte subpopulations compared with residential control. IL-6, but not IL-10, was also slightly but significantly upregulated in the intermediate AMF subpopulation of LPS-treated mice (Fig. 2E) . Interestingly, matrix metalloproteinase 12 (MMP-12) was upregulated in all Mac-1 pos BAL MF subpopulations present after LPS treatment (Fig. 2E) .
Determination of AMF subpopulation origins
We postulated that the CD11c high Mac-1 pos MFs (subpopulation I) observed during acute inflammation could represent residential AMFs undergoing a continuum of Mac-1 upregulation. To confirm the origin of each MF subpopulation, we generated BM chimeras using CD45.1 donors and CD45.2 recipients, which we then challenged with LPS, Mem71, or DMEM (control). Background lung toxicity was observed, as CD45.2 chimeric mice had greater BAL debris and increased BAL MF heterogeneity compared with C57BL/6 mice (Supplemental Fig. 1A ). Four weeks postirradiation and transfer of CD45.1 BM, 70-90% of BAL MFs were CD45.2 + in control chimeric mice, reflecting low residential AMF turnover (Fig. 3A, Supplemental Fig. 1C ) as previously reported (11) . In nonirradiated C57BL/6 (i.e., CD45.2 allotype mice), all peripheral blood leukocytes were CD45.2 + (Supplemental Fig. 1C ). In contrast, $95% of circulating blood monocytes were CD45.1 + 4 wk postirradiation, demonstrating successful blood leukocyte reconstitution with CD45.1 donor BM (Supplemental Fig. 1C) .
In control, LPS-, and Mem71-challenged CD45.2 chimeric mice, 70-90% of all CD11c high Mac-1 neg/low residential AMFs (subpopulation R) were CD45.2 + as expected (Fig. 3A) . BAL monocytes (subpopulation Me and Mv) in challenged chimeras were $95% CD45.1 + , confirming their origin as newly recruited blood monocytes (Fig. 3A) . Interestingly, in challenged chimeric mice, CD11c (Fig. 3A) . The Journal of Immunologymonocytes, were additionally observed in BAL, suggesting that residential AMF Mac-1 upregulation occurs before monocyte recruitment during acute lung inflammation (Fig. 3B) . By day 10, resolution of all lung MFs to a single CD11c high Mac-1 neg/low residential AMF phenotype had occurred in LPS-treated mice. This contrasted greatly with influenza infection, where four discrete MFlike subpopulations still existed, further highlighting differences in MF subpopulation regulation during lung disease (Fig. 3B) .
Identification of AMF subpopulations in chronic lung disease
SHIP-1 is a hematopoietic-specific 59 inositol phosphatase that represses the antiapoptotic and proinflammatory PI3K pathway (20, 26) , which is of particular importance in MFs. M2 AMF polarization was first identified in SHIP-1 2/2 mice that spontaneously developed lung disease (8) , a characteristic of nonrecruited residential tissue MFs, and c-fms low compared with C57BL/6 residential AMFs (Fig. 4C) . Interestingly, SHIP-1 2/2 AMFs were more autofluorescent than C57BL/6 AMFs, with a more diffuse increased cytoplasmic signal observed (Fig. 4D) . SHIP-1
2/2
Mac-1 pos AMFs (subpopulation Rii) were larger, highly vacuolated, and often multinucleated compared with C57BL/6 and SHIP-1 2/2 Mac-1 neg/low AMFs (Fig. 4E) . Cell sorting showed significant upregulation of iNOS and Arg I in both SHIP-1 2/2 AMF subpopulations (Fig. 4F) . Interestingly, high MMP-12 expression segregated with only subpopulation Rii (Fig. 4F) .
Acute cigarette smoke exposure was studied alongside C57BL/6 SHIP-1 2/2 mice as a negative control for the specificity of AMF subpopulation formation in pathological disease. Although cigarette smoke is the major epidemiological cause of COPD and lung cancer, models of acute cigarette exposure do not model the development of chronic lung disease (27) , although neutrophilic lung inflammation is observed (22) . In C57BL/6 mice, acute cigarette smoke exposure did not induce AMF Mac-1 upregulation despite an increase in BAL neutrophil and MF numbers, increased AMF autofluorescence, and AMF granularity. This further indicates that AMF subpopulations may correlate with selective immunological and pathological processes, rather than nonspecifically in all inflammatory lung conditions (Fig. 4A-D) .
AMF subpopulations are disease dependent in SHIP-1
Chronic lung disease is background dependent in SHIP-1 2/2 mice (21); with lung pathology manifest in the C57BL/6 but not BALB/c background at 12 wk (Fig. 5A) . Although deletion of SHIP-1 produces a rare subpopulation of Mac-1 pos AMFs with dendrite-like processes in BALB/c mice, large, morphologically activated Mac-1 pos AMFs are only a characteristic of C57BL/6 SHIP-1 2/2 mice (Fig. 5B, 5C ), thus tracking with lung disease rather than intrinsic SHIP-1 deletion itself.
AMF subpopulations track with spontaneous lung disease induction
We further followed AMF subpopulation deregulation using a novel model of spontaneous lung disease induction. CD45. 5D, 5E ). Eight to 10 mo posttransplantation, when symptoms of illness were first identified, spontaneous granulomatous lung disease was observed in all SHIP-1 2/2 but not C57BL/6 chimeras, and accompanied by Mac-1 high AMF subpopulation formation (Fig.  5D, 5F ). Interestingly, SHIP- 1D ).
Discussion
In this article, to our knowledge, we present the first findings segregating residential MF heterogeneity into distinct subpopulations during acute lung inflammation and chronic inflammatory lung disease. Currently, identification of putative tissue MF subsets is of great interest, because it is now believed that an imbalance of homeostatic versus pathogenic MF subsets may be driving the pathogenesis of inflammation and disease (1) . Recently, differential F4/80 and CD11c surface expression has been used to discriminate distinct MF and dendritic cell subsets in the colon, which shift in balance during gut homeostasis and induced inflammatory disease (28) . In lung, although significant advances have been made in the characterization of dendritic cell subsets (29) , inflammatory lung monocytes and blood-derived exudate MFs (14) , the intense autofluorescence of residential AMFs has rendered the global study of lung MF heterogeneity highly difficult. In this study, we used Mac-1 and CD11c surface expression as a clear segregator of residential as well as emigrating monocyte and lung MF subsets.
In healthy lungs at rest, CD11c high Mac-1 neg/low residential AMFs (subpopulation R) maintain immunological homeostasis through constant removal of innocuous foreign Ags found in the local lung microenvironment (30) and through suppression of inflammatory T cell responses through regulation of pulmonary DC activity and migration (10) . LPS challenge orchestrates two MF-related changes in alveolar airspaces. First, a subpopulation of residential AMFs upregulate Mac-1 expression (subpopulation calculated relative to LPS R of Fig. 2E . Results are mean 6 SEM; *p , 0.05, **p , 0.01, ***p , 0.005; n = 4 from four independent experiments. Asterisk directly above a bar indicates p value compared with DMEM R. I). Shortly afterward, inflammatory blood monocytes (subpopulation M) are recruited into alveolar airspaces where they mediate bactericidal activity directly through phagocytosis and NO production, and indirectly through the amplification of the local inflammatory response. Although recruitment of inflammatory lung monocytes has been well studied (11, 13, 31) , to our knowledge, we are the first to identify their simultaneous expression of both M1-and M2-like MF markers ex vivo. This is significant because the current doctrine tends to regard M1 and M2 MFs as differentially polarized MF subtypes that mediate distinct functions in the tissue microenvironment (32, 33) , trending the identification of a M2 MF based solely on its expression of M2 markers such as Arg I and IL-10. Because lung MFs exist in a microenvironment that is dynamic and complex, ex vivo characterization of functionally distinct subpopulations using flow cytometry may allow us to better understand the role of AMFs in homeostasis and disease.
Monocytes are key effector cells in inflammation and host defense (14) . Interestingly, we also discriminated key differences in the lung monocyte subpopulation postinfection with Mem71 influenza A virus compared with LPS treatment. First, LPS-mediated acute lung inflammation is resolved by day 10, whereas Mem71 infection triggers a longer lasting complex MF recruitment circuit in lung. Second, infiltrating monocytes are more dominant in Mem71-infected compared with LPS-treated mice, with the subpopulation Mv monocytes expressing higher levels of iNOS, IL-6, Arg I, and IL-10. Mem71 is a type A influenza strain of intermediate virulence that, given at sublethal dosages, induces a lung inflammatory response that peaks at day 3 and is resolved by day 10 (34). In contrast, infection with high-fatality influenza A strains (i.e., avian H5N1/97) leads to patient death from acute respiratory distress and multiple organ dysfunction, postulated to be caused by aberrant cytokine production from virus-exposed lung MFs (5, 35) . Interestingly, CCR2
2/2 mice infected with the highly virulent PR8 influenza A strain virus have decreased lung monocyte recruitment and are protected against morbidity and mortality independent of virus clearance efficiency (6, 14) , clearly highlighting the significant contributions of lung monocytes in acute lung disease. In our model of nonlethal influenza infection, we observed the highest levels of iNOS and IL-6, but also Arg I and IL-10, in subpopulation Mv. Arg I suppresses NO production through competition for arginine substrate with iNOS (36) , and its simultaneous upregulation may help regulate NO levels to prevent NO-mediated pneumonitis and mortality after influenza infection (37) . IL-10 deactivates MF proinflammatory cytokine production in vitro (38) . Although IL-10 production by effector T cells is implicated in the suppression of influenza-induced inflammation and lethality (39), we show that the CD11c neg/low Mac-1 high Mv subpopulation already produces IL-10 during the peak innate response. Thus, we postulate that lung monocytes may exhibit both anti-inflammatory and proinflammatory mechanisms in vivo to protect from influenza-induced cytokine dysfunction and mortality. In particular, it will be greatly interesting to examine whether influenza fatality occurs alongside a global imbalance of the lung MF subpopulations or a shift in the M2 , M1 simultaneous characteristics of recruited lung monocytes.
Because it has been known for some time that increased AMF numbers clinically correlate with COPD severity (16, 40) , animal models of chronic inflammatory lung disease are of great interest. Although large vacuolated AMFs are found in almost all animal models of COPD (7, 17, 41, 42) , no single pathological AMF subpopulation has yet been identified or associated with disease pathogenesis. In this article, we report the presence of a subpopulation of constitutively Mac-1 pos residential AMFs in C57BL/6 is a common feature of all COPD animal models (7, 17, 41, 42) , implicating its role as a major COPD effector. Clinically, a minor SNP allele in MMP-12 that reduces its protease activity is protective against COPD onset in smokers (43) . Because MMP-12 expression is also transiently upregulated in Mac-1 pos AMFs after LPS treatment, we postulate that deregulation of SHIP-1 signaling in a susceptible genetic background creates spontaneous AMF heterogeneity wherein chronic AMF Mac-1, and hence MMP-12, expression may be responsible for the lung disease pathogenesis.
In summary, we have used a novel flow cytometry approach to identify and characterize AMF subpopulation heterogeneity in both acute lung inflammation and chronic lung disease. We report Mac-1 as a marker of activated residential AMFs and show that ex vivo lung MFs adopt both M1 and M2-like characteristics during acute inflammation and disease. Specifically, we show that AMF subpopulations are a feature of and track with the development of chronic inflammatory lung disease. This study paves the way for elucidating the role of AMF subpopulations in lung disease pathogenesis, and the possibility of selectively targeting pathological AMF subpopulations to attenuate lung disease.
